Beschreibung
InhaltsangabeThe Incidence and Clinical Significance of Antibodies to Interferon-g in Patients with Solid Tumors; K. Oberg. Interferon Antibodies in Patients with Infectious Diseases; G. Antonelli, et al. Treatment-Induced Antibodies to Interleukin-2; O. Prummer. Natural Antibodies to IL-2; A. Balsari, et al. Natural Antibodies to Interferon-Gamma; A. Caruso, et al. Anti-Cytokine Autoantibodies: Epiphenomenon or Critical Modulators of Cytokine Action; P.H. van der Meide, et al. Potential Therapeutic Use of Antibodies Directed Toward HuIFN-g; G. Froyen, et al. Structure Activity of Type I Interferons; G. Viscomi. Measurement of Cytokine Antibodies. Test Development; M. Svenson, et al. The Expression of Potency of Neutralizing Antibodies for Interferons and Other Cytokines; S.E. Grossberg, et al.
Inhaltsverzeichnis
The Incidence and Clinical Significance of Antibodies to Interferon-g in Patients with Solid Tumors; K. Oberg. Interferon Antibodies in Patients with Infectious Diseases; G. Antonelli, et al. Treatment-Induced Antibodies to Interleukin-2; O. Prummer. Natural Antibodies to IL-2; A. Balsari, et al. Natural Antibodies to Interferon-Gamma; A. Caruso, et al. Anti-Cytokine Autoantibodies: Epiphenomenon or Critical Modulators of Cytokine Action; P.H. van der Meide, et al. Potential Therapeutic Use of Antibodies Directed Toward HuIFN-g; G. Froyen, et al. Structure Activity of Type I Interferons; G. Viscomi. Measurement of Cytokine Antibodies. Test Development; M. Svenson, et al. The Expression of Potency of Neutralizing Antibodies for Interferons and Other Cytokines; S.E. Grossberg, et al.
